Stroke Trial, Recruiting NCT06469463 Sponsor: Hospices Civils de Lyon Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06469463
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthy volunteers (control group):

  • Adults aged 18 or older, male or female.
  • Right-handed people only.
  • People registered with the French healthcare system.
  • People who are motivated to take part in the study.
  • People with normal vision or vision that is fully corrected with glasses or contact lenses.
  • People with a sufficient understanding of French to follow instructions.
  • People who are able to listen to and understand the study instructions.
  • People who are able to sign a written consent form before taking part.
  • People with no history of neurological or psychiatric illness.
  • People with no physical disability affecting the arms or wrists.
  • People who do not take medications that affect the brain or nervous system, and who do not report misusing any substances.

For stroke patients:

  • Adults aged 18 or older, male or female, who have had a stroke.
  • People whose stroke is no longer in the acute (very early) phase.
  • Right-handed people only.
  • People who have movement difficulties in at least one arm or hand as a result of their stroke, and who may have some mild additional difficulties but no cognitive (thinking or memory) problems.
  • People entitled to a French social security scheme.
  • People who are motivated to take part in the study.
  • People with normal vision or vision that is fully corrected with glasses or contact lenses.
  • People with a sufficient understanding of French to follow instructions.
  • People who are able to listen to and understand the study instructions.
  • People who are able to sign a written consent form before taking part.

Who may not be able to join:

  • People who experience claustrophobia (fear of enclosed spaces), as this is incompatible with the brain scanning equipment used in the study.
  • People in the control group who have any motor (movement) impairment, or anyone who has had a severe traumatic brain injury.
  • People who have had a chronic (long-standing) stroke (applies to both groups).
  • People with a history of skin diseases or serious or multiple skin allergies.
  • People who have had an MRI scan within two weeks before the experiment.
  • People who have any metal implants in their body, including dental work containing metal, root canals, pacemakers, or cochlear implants.
  • People whose work involves regular exposure to metals.
  • Women who are pregnant or breastfeeding (confirmed by a urine test).
  • People who are unable to sit for longer than two hours (each session is approximately two and a half hours).
  • People with alcohol dependence, or anyone who has consumed alcohol or drugs in the 24 hours before the experiment.
  • People currently taking medications that may strongly affect brain signal recordings, such as antidepressants or stimulant medications.
  • People who, in the investigator's opinion, are unable or unwilling to follow the study procedures.
  • People under guardianship or legal protection.
  • People in emergency situations who are unable to give consent.
  • People under 18 years of age.
  • People with any of the following implants or devices, which are incompatible with the brain scanning equipment: pacemaker, implanted pump (including insulin pump), neurostimulator, cochlear implants or other hearing aids, metal prosthesis, surgical aneurysm clips in the brain, ferromagnetic (metal) foreign bodies in or near the head or upper body, or neurosurgical shunt valves.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 04 72 13 89 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 March 2026
Est. completion
1 August 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Develop subject-specific generative models

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov